Microbot Medical (MBOT) Cash from Financing Activities (2016)
Historic Cash from Financing Activities for Microbot Medical (MBOT) over the last 7 years, with Q4 2016 value amounting to $2.2 million.
- Microbot Medical's Cash from Financing Activities rose 11068.69% to $2.2 million in Q4 2016 from the same period last year, while for Dec 2016 it was $8.9 million, marking a year-over-year increase of 205233.58%. This contributed to the annual value of $7.9 million for FY2024, which is 2101.25% up from last year.
- Latest data reveals that Microbot Medical reported Cash from Financing Activities of $2.2 million as of Q4 2016, which was up 11068.69% from $154000.0 recorded in Q3 2016.
- Microbot Medical's 5-year Cash from Financing Activities high stood at $23.7 million for Q2 2015, and its period low was -$20.4 million during Q4 2015.
- For the 5-year period, Microbot Medical's Cash from Financing Activities averaged around $4.7 million, with its median value being $2.3 million (2012).
- Within the past 5 years, the most significant YoY rise in Microbot Medical's Cash from Financing Activities was 340188.57% (2015), while the steepest drop was 194854.18% (2015).
- Microbot Medical's Cash from Financing Activities (Quarter) stood at $5.6 million in 2012, then surged by 199.11% to $16.8 million in 2013, then plummeted by 105.94% to -$995315.0 in 2014, then crashed by 1948.54% to -$20.4 million in 2015, then skyrocketed by 110.69% to $2.2 million in 2016.
- Its Cash from Financing Activities stands at $2.2 million for Q4 2016, versus $154000.0 for Q3 2016 and $750000.0 for Q2 2016.